Hormonothérapie dans le cancer de la prostate : quel rôle pour l’IDE en 2020 ?
暂无分享,去创建一个
[1] E. Oger,et al. Androgen deprivation therapy prescription, blood and bone-density testing in a French population-based study exploring adherence to the French prostate cancer guidelines. , 2020, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.
[2] Prashanth Rawla,et al. Epidemiology of Prostate Cancer , 2019, World journal of oncology.
[3] A. Ouzzane,et al. Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate , 2018, Progrès en Urologie.